{"slideshow_credits": null, "snippet": "Pershing Square, the hedge fund run by William A. Ackman, contends that Allergan has not made it clear whether calling a special meeting of Allergan shareholders would set off its shareholder rights plan.", "abstract": "Pershing Square, the hedge fund run by William A. Ackman, contends that Allergan has not made it clear whether calling a special meeting of Allergan shareholders would set off its shareholder rights plan.", "section_name": "Business Day", "print_page": null, "document_type": "blogpost", "byline": {"person": [{"firstname": "David", "role": "reported", "lastname": "GELLES", "rank": 1, "organization": ""}], "original": "By DAVID GELLES"}, "web_url": "http://dealbook.nytimes.com/2014/06/13/allergan-sued-over-poison-pill-trigger/", "lead_paragraph": null, "headline": {"main": "Ackman's Hedge Fund Sues Botox Maker Allergan Over Poison Pill Trigger", "kicker": "DealBook"}, "_id": "539af24738f0d83101a1d1e0", "word_count": "524", "multimedia": [{"height": 126, "url": "images/2014/06/03/business/dbpix-allergan1/dbpix-allergan1-thumbWide.jpg", "legacy": {"wideheight": "126", "wide": "images/2014/06/03/business/dbpix-allergan1/dbpix-allergan1-thumbWide.jpg", "widewidth": "190"}, "subtype": "wide", "width": 190, "type": "image"}, {"height": 373, "url": "images/2014/06/03/business/dbpix-allergan1/dbpix-allergan1-articleLarge.jpg", "legacy": {"xlarge": "images/2014/06/03/business/dbpix-allergan1/dbpix-allergan1-articleLarge.jpg", "xlargewidth": "600", "xlargeheight": "373"}, "subtype": "xlarge", "width": 600, "type": "image"}, {"height": 75, "url": "images/2014/06/03/business/dbpix-allergan1/dbpix-allergan1-thumbStandard.jpg", "legacy": {"thumbnail": "images/2014/06/03/business/dbpix-allergan1/dbpix-allergan1-thumbStandard.jpg", "thumbnailwidth": "75", "thumbnailheight": "75"}, "subtype": "thumbnail", "width": 75, "type": "image"}], "pub_date": "2014-06-13T08:43:15Z", "source": "The New York Times", "news_desk": "Business", "keywords": [{"name": "persons", "value": "Ackman, William A", "rank": "1"}, {"name": "organizations", "value": "Pershing Square Capital Management", "rank": "2"}, {"name": "organizations", "value": "Valeant Pharmaceuticals International Inc", "rank": "3"}, {"name": "organizations", "value": "Allergan Inc", "rank": "1"}, {"name": "subject", "value": "Suits and Litigation (Civil)", "rank": "3"}, {"name": "subject", "value": "Shareholder Rights and Activism", "rank": "2"}, {"name": "subject", "value": "Mergers, Acquisitions and Divestitures", "rank": "1"}], "blog": [], "subsection_name": "Dealbook", "type_of_material": "Blog"}